These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 34044275)

  • 1. Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease.
    Zhang L; Ocansey DKW; Liu L; Olovo CV; Zhang X; Qian H; Xu W; Mao F
    Biomed Pharmacother; 2021 Aug; 140():111752. PubMed ID: 34044275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute small intestinal inflammation results in persistent lymphatic alterations.
    Rehal S; Stephens M; Roizes S; Liao S; von der Weid PY
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G408-G417. PubMed ID: 29351397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal Cancer in Inflammatory Bowel Disease: A Review of the Role of Gut Microbiota and Bacterial Biofilms in Disease Pathogenesis.
    Muñiz Pedrogo DA; Sears CL; Melia JMP
    J Crohns Colitis; 2024 Oct; 18(10):1713-1725. PubMed ID: 38703073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenteric Lymphatic Alterations Observed During DSS Induced Intestinal Inflammation Are Driven in a TLR4-PAMP/DAMP Discriminative Manner.
    Stephens M; Liao S; von der Weid PY
    Front Immunol; 2019; 10():557. PubMed ID: 30972059
    [No Abstract]   [Full Text] [Related]  

  • 5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of lymphatics in inflammatory bowel disease.
    Alexander JS; Chaitanya GV; Grisham MB; Boktor M
    Ann N Y Acad Sci; 2010 Oct; 1207 Suppl 1():E75-85. PubMed ID: 20961310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease.
    Ocansey DKW; Pei B; Xu X; Zhang L; Olovo CV; Mao F
    J Transl Med; 2021 Jun; 19(1):254. PubMed ID: 34112196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.
    D'Alessio S; Correale C; Tacconi C; Gandelli A; Pietrogrande G; Vetrano S; Genua M; Arena V; Spinelli A; Peyrin-Biroulet L; Fiocchi C; Danese S
    J Clin Invest; 2014 Sep; 124(9):3863-78. PubMed ID: 25105363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic dysregulation in intestinal inflammation: new insights into inflammatory bowel disease pathomechanisms.
    Becker F; Yi P; Al-Kofahi M; Ganta VC; Morris J; Alexander JS
    Lymphology; 2014 Mar; 47(1):3-27. PubMed ID: 25109166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
    Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
    Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease.
    D'Alessio S; Tacconi C; Fiocchi C; Danese S
    Curr Opin Gastroenterol; 2013 Nov; 29(6):608-13. PubMed ID: 24100721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
    Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota.
    Regner EH; Ohri N; Stahly A; Gerich ME; Fennimore BP; Ir D; Jubair WK; Görg C; Siebert J; Robertson CE; Caplan L; Frank DN; Kuhn KA
    Arthritis Res Ther; 2018 Jul; 20(1):149. PubMed ID: 30029674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
    Aldars-García L; Marin AC; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advance on the interaction between gut microbes and cytokines in inflammatory bowel disease].
    Lu X; Zhang S; Li X; Li H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jul; 40(7):655-659. PubMed ID: 39179410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.